spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  CeloNova Biosciences 

 HSMN NewsFeed - 6 Aug 2019
CeloNova Announces Appointment of New President and CEO
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 1 Mar 2017
CeloNova Biosciences Receives FDA Approval of COBRA PzF(TM) Stent System
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 8 Aug 2016
Seno Medical Instruments Appoints Eric Davis as Chief Financial Officer
Devices Diagnostics Oncology Personnel
 HSMN NewsFeed - 10 Nov 2015
Boston Scientific To Acquire Interventional Radiology Business Of CeloNova Biosciences
Devices Interventional Radiology Oncology Acquisitions
 HSMN NewsFeed - 16 Sep 2014
First-In-Man Study of the COBRA PzF(TM) Coronary Stent Shows Promising Results Highlighted by Short, 30-Day Dual-Antiplatelet Therapy and Low, 3% TLR Rate
Devices Interventional Cardiology
 HSMN NewsFeed - 18 Mar 2014
CeloNova’s Coronary Stent System Could Mean Faster Healing of Arteries and Greatly Reduced Use of Blood-thinning Medication
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 6 Oct 2009
Scientific Paper Supports Micro-Bland Embolization Technique for Liver Cancer With Embozene(TM) Microspheres
Devices Oncology
 HSMN NewsFeed - 16 Sep 2009
New Micro-Bland Embolization Technique with Embozene(TM) Microspheres to Be Presented at the International Medical Conference in Lisbon, Portugal
Devices Oncology
 HSMN NewsFeed - 1 Jan 2009
First U.S. Implants of Newly Approved Embozene(TM) Color-Advanced Microspheres Embolization Platform
Devices Interventional Oncology
 HSMN NewsFeed - 16 Dec 2008
CeloNova BioSciences Receives FDA Market Approval for Embozene(TM) Color-Advanced Microspheres Embolization Platform
Devices Interventional FDA
 HSMN NewsFeed - 13 Oct 2008
12-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions
Devices Interventional Cardiology
 HSMN NewsFeed - 7 Oct 2008
CeloNova BioSciences to Showcase the CE-Marked CATANIA(TM) Coronary Stent System Featuring NanoThin Polyzene(R)-F at TCT Debut
Devices Interventional Cardiology
 HSMN NewsFeed - 21 Jan 2008
Super-Thin Drug-Free Coating 'Hides' Stent as It Unblocks Heart Arteries
Devices Interventional Cardiology
 HSMN NewsFeed - 20 Jan 2008
CeloNova BioSciences Announces Positive Results from European Study of Embozene(TM) Microspheres for Treatment of Uterine Fibroids
Devices Interventional
 HSMN NewsFeed - 20 Jan 2008
CeloNova BioSciences Introduces a New Class of Coronary Stent: The CATANIA(TM) Coronary Stent System with NanoThin Polyzene(R)-F
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Oct 2006
CeloNova Announces Technology that Solves Stent Problems
Devices Interventional Cardiology
Return to NewsFeed  
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.